| Old Articles: <Older 23801-23810 Newer> |
|---|
 |
The Motley Fool
June 8, 2007
Joe Magyer |
Avoid the Next Dividend Implosion Dividend stocks may have a reputation of being safe or stodgy, but sometimes they're anything but. Here are three keys to help you spot a dividend cut from a mile away.   |
The Motley Fool
June 8, 2007
Seth Jayson |
No Solution at McDonald's Nice comps report, but is the good news enough to warrant buying the stock? These days, McDonald's no longer looks like the bargain it's been in years past. |
The Motley Fool
June 8, 2007 |
National Semi Gets Whole: Fool by Numbers The analog chip maker released earnings for the fourth-quarter 2007: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... |
The Motley Fool
June 8, 2007
Alyce Lomax |
Target Whacks Wal-Mart Investors, one month of sales data doesn't make a good investment thesis, of course, but Target has outshined Wal-Mart many times over the last year and so investors probably see a pattern emerging. |
The Motley Fool
June 8, 2007 |
Quality Systems Grows On: Fool by Numbers The medical software maker released fourth-quarter 2007 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... |
The Motley Fool
June 8, 2007
Emil Lee |
Fool on the Street: Hilton's Glamorous Plans The hotelier's strategy includes slimming down and looking abroad. Investors, take note. |
The Motley Fool
June 8, 2007
Billy Fisher |
Smithfield Brings Home the Bacon Strong pork sales drive Smithfield Foods' big quarter. Investors, take note. |
The Motley Fool
June 8, 2007
Brian Lawler |
Lilliputian Attack on Lilly? While every investor should have some degree of exposure to pharmaceutical stocks, recent patent decisions in two of the biggest pharmaceutical drugs markets should serve as a warning of the potential litigation dangers when investing in some of the sector's giants. |
The Motley Fool
June 8, 2007
Brian Lawler |
QLT Eats Itself The beleaguered specialty pharmaceutical opens up another share buyback plan. |
The Motley Fool
June 8, 2007
Steven Mallas |
Another Mutation for the Monster First it was the CEO, and now the CFO has left, too. What should Monster Worldwide's shareholders be thinking? |
| <Older 23801-23810 Newer> Return to current articles. |
